ImmunoCellular Therapeutics (FRA:KOL1) YoY Rev. per Sh. Growth : 0.00% (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is ImmunoCellular Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. ImmunoCellular Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2018 was 0.00%.

ImmunoCellular Therapeutics's Revenue per Share for the three months ended in Jun. 2018 was €0.00.

ImmunoCellular Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for ImmunoCellular Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoCellular Therapeutics YoY Rev. per Sh. Growth Chart

ImmunoCellular Therapeutics Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

ImmunoCellular Therapeutics Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-	-	-	-	-

ImmunoCellular Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

ImmunoCellular Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2017 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2017 )
=	(Revenue per Share (A: Dec. 2017 )	-	Revenue per Share (A: Dec. 2016 ))	/	\| Revenue per Share (A: Dec. 2016 ) \|
=	(0	-	0)	/	\| 0 \|
=	N/A %

ImmunoCellular Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2018 is calculated as:

	YoY Rev. per Sh. Growth (Q: Jun. 2018 )
=	(Revenue per Share (Q: Jun. 2018 )	-	Revenue per Share (Q: Jun. 2017 ))	/	\| Revenue per Share (Q: Jun. 2017 )) \|
=	(0	-	0)	/	\| 0 \|
=	N/A %

ImmunoCellular Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of ImmunoCellular Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoCellular Therapeutics (FRA:KOL1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoCellular Therapeutics Ltd (FRA:KOL1) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

136 Summit Avenue, Suite 100, Montvale, NJ, USA, 07645

Website

https://www.eompharma.com

EOM Pharmaceutical Holdings Inc is focused on developing novel immunomodulatory and retinal disease drug agents to address a range of inflammatory, viral, retinal, and other diseases. Its product candidate includes dual-acting broad-spectrum immunomodulator EOM613, which has the potential to treat cancer cachexia and rheumatoid arthritis, and its advanced formulation of EOM147 is being studied to treat serious retinal diseases without the need for intraocular injection.

ImmunoCellular Therapeutics (FRA:KOL1) Headlines

No Headlines